| - Industry | - Sector | Ms. Lijuan Fan CEO | XSHE Exchange | CNE1000021X8 ISIN |
| CN Country | 188 Employees | - Last Dividend | 18 May 2016 Last Split | - IPO Date |
Kunming Longjin Pharmaceutical Co., Ltd. specializes in developing and distributing therapeutic medicines aimed at individuals suffering from cardiovascular, cerebrovascular, and metabolic diseases within China. Founded in 1996, the company has established its headquarters in Kunming, China, marking a significant presence in the pharmaceutical sector. Beyond its primary focus on healthcare products, Kunming Longjin Pharmaceutical has diversified into the cultivation of industrial hemp, expanding its portfolio into the dynamic consumer product sphere and agricultural business.
The products and services offered by Kunming Longjin Pharmaceutical Co., Ltd. cater to a wide range of health-related needs, extending from specific medication for diseases to general wellness products. Here is a closer look at their diverse offerings: